The transcription factor FOXM1 is a cellular target of the natural product thiostrepton

Nature Chemistry

Volumn 3, Issue 9, 2011, Pages 725-731

  Hegde, Nagaratna S ^a   Sanders, Deborah A ^b   Rodriguez, Raphaël ^a   Balasubramanian, Shankar ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; CELL EXTRACT; DNA; DRUG DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; THIOSTREPTON;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; HUMAN; METABOLISM; PROTEIN BINDING; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; BIOLOGICAL PRODUCTS; CELL EXTRACTS; CELL LINE, TUMOR; DNA; DRUG DESIGN; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTEIN BINDING; THIOSTREPTON;

EID: 80052111561     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1114     Document Type: Article

References (45)

1. Schreiber, S. L. The small-molecule approach to biology. Chem. Eng. News 81, 51-61 (2003).
2. Stockwell, B. R. Chemical genetics: Ligand-based discovery of gene function. Nat. Rev. Genet. 1, 116-125 (2000).
3. Altmann, K-H. et al. The state of the art of chemical biology. ChemBioChem 10, 16-29 (2009).
4. Tan, D. S. Diversity-oriented synthesis: Exploring the intersections between chemistry and biology. Nat. Chem. Biol. 1, 74-84 (2005).
5. Berg, T. Inhibition of transcription factors with small organic molecules. Curr. Opin. Chem. Biol. 12, 464-471 (2008).
6. Arndt, H-D. Small molecule modulators of transcription. Angew. Chem. Int. Ed. 45, 4552-4560 (2006). (Pubitemid 44106070)
7. Gottesfeld, J. M., Neely, L., Trauger, J.W., Baird, E. E. & Dervan, P. B. Regulation of gene expression by small molecules. Nature 387, 202-205 (1997). (Pubitemid 27209438)
8. Kung, A. L. et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell. 6, 33-43 (2004). (Pubitemid 38903160)
9. Ng, P. Y., Tang, Y., Knosp,W. M., Stadler, H. S. & Shaw, J. T. Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor. Angew. Chem. Int. Ed. 46, 5352-5355 (2007). (Pubitemid 47067632)
10. Verdine, G. L. &Walensky, L. D. The challenge of drugging undruggable targets in cancer: Lessons learned from targeting BCL-2 family members. Clin. Cancer Res. 13, 7264-7270 (2007).
11. Bauer, R. A., Wurst, J. M. & Tan, D. S. Expanding the range of 'druggable' targets with natural product-based libraries: An academic perspective. Curr. Opin. Chem. Biol. 14, 308-314 (2010).
12. Koehler, A. N. A complex task? Direct modulation of transcription factors with small molecules. Curr. Opin. Chem. Biol. 14, 331-340 (2010).
13. Lai, E. et al. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev. 4, 1427-1436 (1990).
14. Weigel, D., Jürgens, G., Küttner, F., Seifert, E. & Jäckle, H. The homeotic gene forkhead encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57, 645-658 (1989).
15. Krupczak-Hollis, K. et al. The mouse forkhead box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev. Biol. 276, 74-88 (2004). (Pubitemid 39452847)
16. Kalin, T. V. et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res. 66, 1712-1720 (2006). (Pubitemid 43259956)
17. Myatt, S. S. & Lam, E. W-F. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7, 847-859 (2007). (Pubitemid 350006253)
18. Pagano, J. F., Weinstein, M. J., Stout, H. A. & Donovick, R. Thiostrepton, a new antibiotic. I. In vitro studies. Antibiot. Ann. 554-559 (1955/1956).
19. Vendeputte, J. & Dutcher, J. D. Thiostrepton, a new antibiotic. II. Isolation and chemical characterization. Antibiot. Ann. 560-561 (1955/1956).
20. Steinberg, B. A., Jambor, W. P. & Suydam, L. O. Thiostrepton, a new antibiotic. III. In vivo studies. Antibiot. Ann. 562-565 (1955/1956).
21. Bagley, M. C., Dale, J. W., Merritt, E. A. & Xiong, X. Thiopeptide antibiotics. Chem. Rev. 105, 685-714 (2005). (Pubitemid 40351637)
22. Bhat, U. G., Zipfel, P. A., Tyler, D. S. & Gartel, A. L. Novel anticancer compounds induce apoptosis in melanoma cells. Cell Cycle 7, 1851-1855 (2008). (Pubitemid 351988751)
23. Bowling, B. D., Doudican, N., Manga, P. & Orlow, S. J. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother. Pharmacol. 63, 37-43 (2008).
24. Nicolaou, K. C. et al. Discovery of a biologically active thiostrepton fragment. J. Am. Chem. Soc. 127, 15042-15044 (2005). (Pubitemid 41547368)
25. Kwok, J. M. et al. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol. Cancer Ther. 7, 2022-2032 (2008).
26. Bhat, U. G., Halasi, M. & Gartel, A. L. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PloS One 4, e5592 (2009).
27. Bhat, U. G., Halasi, M. & Gartel, A. L. FoxM1 is a general target for proteasome inhibitors. PloS One 4, e6593 (2009).
28. Schoof, S. et al. Antiplasmodial thiostrepton derivatives: Proteasome inhibitors with a dual mode of action. Angew. Chem. Int. Ed. 49, 3317-3321 (2010).
29. Zhang, L. et al. Antibiotic susceptibility of mammalian mitochondrial translation. FEBS Lett. 579, 6423-6427 (2005). (Pubitemid 41612162)
30. Halasi, M. & Gartel, A. L. A novel mode of FoxM1 regulation: Positive autoregulatory loop. Cell Cycle 8, 1966-1967 (2009).
31. Leslie, B. J. & Hergenrother, P. J. Identification of the cellular targets of bioactive small organic molecules using affinity reagents. Chem. Soc. Rev. 37, 1347-1360 (2008).
32. Anderson, B., Hodgkin, D. C. & Viswamitra, M. A. The structure of thiostrepton. Nature 225, 233-235 (1970).
33. Schoof, S., Baumann, S., Ellinger, B. & Arndt, H-D. A fluorescent probe for the 70 S-ribosomal GTPase-associated center. ChemBiochem 10, 242-245 (2009).
34. Wierstral, I. & Alves, J. Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains. Biol. Chem. 387, 963-976 (2006). (Pubitemid 44100243)
35. Yao, K. M., Sha, M., Lu, Z. & Wong, G. G. Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J. Biol. Chem. 272, 19827-19836 (1997). (Pubitemid 27340077)
36. Block, K. M. et al. Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine. J. Am. Chem. Soc. 131, 18078-18088 (2009).
37. Wierstra, I. & Alves, J. Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1. Biochem. Biophys. Res. Commun. 368, 107-115 (2008).
38. Wang, I-C. et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25, 10875-10894 (2005). (Pubitemid 41747132)
39. Leung, T.W. C. et al. Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett. 507, 59-66 (2001). (Pubitemid 33000299)
40. Doisneau-Sixou, S. F. et al. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr. Relat. Cancer 10, 179-186 (2003). (Pubitemid 36758647)
41. Rae, J. M. et al. GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 92, 141-149 (2005). (Pubitemid 40933578)
42. Gomez, B. P. et al. Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 21, 4013-4027 (2007). (Pubitemid 350232358)
43. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33 (2011).
44. Schmidt, D. et al. ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240-248 (2009).
45. Gemenetzidis, E. et al. Induction of human epithelial stem/progenitor expansion by FOXM1. Cancer Res. 70, 9515-9526 (2010).